Page last updated: 2024-10-25

ciclopirox and Reperfusion Injury

ciclopirox has been researched along with Reperfusion Injury in 1 studies

Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.

Research Excerpts

ExcerptRelevanceReference
"Deferoxamine-treated control myocytes responded similarly."1.35Hypoxia inducible factor-1 improves the actions of positive inotropic agents in stunned cardiac myocytes. ( Luciano, JA; Scholz, PM; Tan, T; Weiss, HR, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tan, T1
Luciano, JA1
Scholz, PM1
Weiss, HR1

Other Studies

1 other study available for ciclopirox and Reperfusion Injury

ArticleYear
Hypoxia inducible factor-1 improves the actions of positive inotropic agents in stunned cardiac myocytes.
    Clinical and experimental pharmacology & physiology, 2009, Volume: 36, Issue:9

    Topics: Animals; Antifungal Agents; Calcium Signaling; Cardiotonic Agents; Ciclopirox; Colforsin; Deferoxami

2009